Katalog
Hilfe
Bauen Sie hier Ihr Portfolio auf
Geben Sie die Menge neben den benötigten Aktien ein – Ihr Portfolio wird automatisch erstellt.
Schneller Screener: nach Kategorie und Empfehlung filtern, Fundamentaldaten, Kennzahlen und Unternehmensprofile überprüfen.
| Unternehmen | Kategorie | Preis | Δ% | Div% | Vol20 | EPS(TTM) | QoQ | EPS(SPR) | Stil | Horizont | Pot. | Risiko | Empfehlung | Portfolio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abivax (ABVX) | Biotechnologie | 115.95 | -2.94% | 0.0% | 1.7% | -5.84 | -200.0% | 24.9% | Wachstum | Mittel | 30 | 80 | Verkaufen |
|
| Alnylam Pharmaceuticals (ALNY) | Biotechnologie | 247.51 | -4.07% | 0.0% | 2.8% | 6.10 | 10.6% | -25.8% | Wachstum | Mittel | 53 | 67 | Halten |
|
| Amgen (AMGN) | Biotechnologie | 382.47 | -2.25% | 2.5% | 2.6% | 16.22 | 16.7% | 11.9% | Wachstum | Mittel | 60 | 70 | Halten |
|
| Apogee Therapeutics (APGE) | Biotechnologie | 135.07 | 0.00% | 0.0% | 0.0% | -4.34 | 0.0% | -6.5% | Wachstum | Lang | 33 | 70 | Verkaufen |
|
| Arrowhead Pharmaceuticals (ARWR) | Biotechnologie | 82.76 | +0.16% | 0.0% | 1.8% | -2.24 | 2.1% | -6.3% | Wachstum | Mittel | 51 | 70 | Halten |
|
| Atai Life Sciences (ATAI) | Biotechnologie | 7.35 | +0.82% | 91.3% | 0.5% | -2.90 | 78.6% | 15.6% | Wachstum | Mittel | 67 | 65 | Halten |
|
| Bio-Techne (TECH) | Biotechnologie | 72.08 | -0.24% | 0.6% | 0.1% | 1.17 | 3.1% | 0.2% | Wachstum | Mittel | 62 | 40 | Kaufen |
|
| BioCryst Pharmaceuticals (BCRX) | Biotechnologie | 8.29 | -5.85% | 0.0% | 2.7% | -1.44 | 39.5% | 0.0% | Wachstum | Mittel | 44 | 70 | Verkaufen |
|
| Biogen (BIIB) | Biotechnologie | 215.43 | +2.23% | 0.0% | 1.8% | 5.68 | 10.4% | 17.0% | Wachstum | Mittel | 65 | 69 | Halten |
|
| Biohaven (BHVN) | Biotechnologie | 12.79 | -14.73% | 0.0% | 5.1% | -4.64 | 0.0% | -19.6% | Wachstum | Mittel | 30 | 75 | Verkaufen |
|
| BioMarin Pharmaceutical (BMRN) | Biotechnologie | 65.51 | +1.71% | 0.0% | 1.6% | 0.38 | 29.2% | 26.7% | Wachstum | Mittel | 76 | 39 | Kaufen |
|
| BioNTech (BNTX) | Biotechnologie | 96.40 | -1.76% | 0.0% | 5.5% | -6.73 | -12.0% | -54.3% | Wachstum | Mittel | 34 | 75 | Verkaufen |
|
| CAMP4 Therapeutics (CAMP) | Biotechnologie | 4.34 | +0.23% | 0.0% | 5.1% | -2.23 | 37.5% | -174.3% | Wachstum | Mittel | 38 | 70 | Halten |
|
| Celcuity (CELC) | Biotechnologie | 85.49 | -5.10% | 0.0% | 2.5% | -4.29 | 0.0% | -24.1% | Wachstum | Mittel | 29 | 76 | Verkaufen |
|
| Cidara Therapeutics (CDTX) | Biotechnologie | 221.38 | 0.00% | 0.0% | 0.0% | -11.78 | 0.0% | 0.0% | Wachstum | Mittel | 30 | 80 | Verkaufen |
|
| Corcept Therapeutics (CORT) | Biotechnologie | 114.92 | -0.67% | 0.0% | 1.5% | 0.52 | 55.3% | 1383.3% | Wachstum | Mittel | 73 | 34 | Kaufen |
|
| Corvus Pharmaceuticals (CRVS) | Biotechnologie | 12.94 | -2.93% | 0.0% | 2.4% | -0.64 | 0.0% | -19.4% | Wachstum | Mittel | 32 | 73 | Verkaufen |
|
| Crinetics Pharmaceuticals (CRNX) | Biotechnologie | 84.95 | 0.00% | 0.0% | 0.1% | -5.05 | 134.0% | 0.0% | Wachstum | Mittel | 70 | 60 | Halten |
|
| Definium Therapeutics (DFTX) | Biotechnologie | 37.73 | -0.68% | 0.0% | 2.8% | -3.44 | 0.0% | -166.2% | Wachstum | Mittel | 39 | 76 | Verkaufen |
|
| Dianthus Therapeutics (DNTH) | Biotechnologie | 103.28 | -3.51% | 0.0% | 2.2% | -0.13 | 64.4% | 0.0% | Wachstum | Lang | 60 | 50 | Halten |
|
| Disc Medicine (IRON) | Biotechnologie | 74.14 | -3.10% | 0.0% | 1.2% | -6.60 | 0.0% | 9.9% | Wachstum | Mittel | 49 | 66 | Halten |
|
| Forte Biosciences (FBRX) | Biotechnologie | 76.99 | 0.00% | 0.0% | 0.0% | -4.59 | 0.0% | 10.2% | Wachstum | Mittel | 70 | 69 | Halten |
|
| Illumina Inc. (ILMN) | Biotechnologie | 201.27 | -1.82% | 0.0% | 2.9% | 5.41 | 6.2% | 6.5% | Wachstum | Lang | 65 | 70 | Halten |
|
| ImmunityBio (IBIO) | Biotechnologie | 1.23 | -2.78% | 0.0% | 2.6% | -0.33 | -100.0% | 39.0% | Wachstum | Mittel | 20 | 85 | Verkaufen |
|
| Immunovant (IMVT) | Biotechnologie | 38.10 | -1.68% | 0.0% | 1.6% | -2.82 | 0.0% | -19.3% | Wachstum | Mittel | 40 | 70 | Verkaufen |
|
| Insmed (INSM) | Biotechnologie | 127.28 | -1.18% | 0.0% | 1.9% | -4.11 | 39.1% | 91.1% | Wachstum | Mittel | 60 | 70 | Halten |
|
| Intellia Therapeutics (NTLA) | Biotechnologie | 11.93 | -2.29% | 0.0% | 4.2% | -3.36 | -49.1% | -0.1% | Wachstum | Mittel | 30 | 80 | Verkaufen |
|
| Ionis Pharmaceuticals (IONS) | Biotechnologie | 55.65 | -0.66% | 0.0% | 0.0% | -3.46 | 8.9% | 0.0% | Wachstum | Lang | 24 | 75 | Verkaufen |
|
| Jazz Pharmaceuticals (JAZZ) | Biotechnologie | 240.48 | -0.34% | 0.0% | 1.8% | 15.20 | 13.0% | -7.6% | Ausgewogen | Mittel | 64 | 40 | Kaufen |
|
| Kura Oncology (KURA) | Biotechnologie | 11.57 | -4.30% | 0.0% | 3.9% | -3.37 | 14.3% | 12.2% | Wachstum | Mittel | 66 | 63 | Kaufen |
|